Credit Suisse Starts Enhabit Home Health & Hospice (EHAB) at Neutral
Tweet
Share
E-mailGet Alerts EHAB Hot Sheet
Price: $13.80 --0%
Rating Summary:
1 Buy, 10 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
1 Buy, 10 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Credit Suisse analyst A.J. Rice initiates coverage on Enhabit Home Health & Hospice (NYSE: EHAB) with a Neutral rating and a price target of $19.00.
For an analyst ratings summary and ratings history on Enhabit Home Health & Hospice click here. For more ratings news on Enhabit Home Health & Hospice click here.
Shares of Enhabit Home Health & Hospice closed at $15.85 yesterday.
You May Also Be Interested In
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
- Oppenheimer Starts Carriage Services (CSV) at Outperform
- RBC Capital Starts Krystal Biotech (KRYS) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
